Contribution of inherited thrombophilia to recurrent miscarriage in the Polish population
Abstract
Introduction: The aim of the study was to evaluate the contribution of genetic variants determining inherited thrombophilia to recurrent miscarriage (RM) in the Polish population. The following polymorphisms were analyzed: 1691G>A, 1328T>C of coagulation factor V, 20210G>A of coagulation factor II, R353Q (11496G>A) of coagulation factor VII, 667C>T, 1298A>C, 1793G>A of MTHFR.
Material and methods: A total of 359 women with ≥ 2 subsequent recurrent miscarriages (303 < 13 weeks of gestation (w.g.) and 56 between 13–22 w.g.) and 400 healthy controls were included in the study. Frequency of the genetic polymorphisms was determined with the PCR/RFLP method.
Results: Higher frequency of the 20210GA genotype was found in the RM < 13 w.g. (2.97 vs. 1.50% in controls, OR = 2.01, ns) and the RM 13–22 w.g. (5.36 vs. 1.50% in controls, OR = 3.72, p = 0.09) subgroups. Statistically significantly higher frequency of the 11496GA genotype was noted in controls as compared to the RM 13–22 w.g. subgroup (10.71 vs. 23.00% in controls, OR = 0.40, p = 0.02). Statistically significantly higher frequency of the 1793GA genotype was observed in the RM < 13 w.g. subgroup as compared to controls (12.21 vs. 7.75% in controls, OR = 1.66, p = 0.03). No significant correlations were found as far as the rest of the analyzed polymorphisms are concerned.
Conclusions: The obtained results suggest that the 1793G>A MTHFR, R353Q (11496G>A) factor VII gene and the 20210G>A factor II gene polymorphisms play a role in the etiology of RM in the Polish population.
Keywords: recurrent miscarriageinherited thrombophiliagenetic polymorphism
References
- Saito S. The causes and treatment of recurrent pregnancy loss. JMAJ. 2009; 52: 97–102.
- Rambaldi MP, Mecacci F, Guaschino S, et al. Inherited and acquired thrombophilias. Reprod Sci. 2014; 21(2): 167–182.
- Middeldorp S. Anticoagulation in pregnancy complications. Hematology Am Soc Hematol Educ Program. 2014; 2014(1): 393–399.
- Ford HB, Schust DJ. Recurrent pregnancy loss: etiology, diagnosis, and therapy. Rev Obstet Gynecol. 2009; 2(2): 76–83.
- Alonso A, Soto I, Urgellés MF, et al. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol. 2002; 187(5): 1337–1342.
- Bennett SA, Bagot CN, Arya R. Pregnancy loss and thrombophilia: the elusive link. Br J Haematol. 2012; 157(5): 529–542.
- Vaiman D. Genetic regulation of recurrent spontaneous abortion in humans. Biomed J. 2015; 38(1): 11–24.
- Cao Y, Zhang Z, Xu J, et al. The association of idiopathic recurrent pregnancy loss with polymorphisms in hemostasis-related genes. Gene. 2013; 530(2): 248–252.
- Carp H, Salomon O, Seidman D, et al. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Hum Reprod. 2002; 17(6): 1633–1637.
- Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res. 2003; 109(2-3): 73–81.
- Kupferminc JM. Management of thrombophilia in women with PVC. Thromb Res. 2005; 115 Suppl 1: 46–50.
- Onderoglu L, Baykal C, Al RA, et al. High frequency of thrombophilic disorders in women with recurrent fetal miscarriage. Clin Exp Obstet Gynecol. 2006; 33(1): 50–54.
- Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systemic review. Br J Haematol. 2006; 132: 171–196.
- Johnson CM, Mureebe L, Silver D. Hypercoagulable states: a review. Vasc Endovascular Surg. 2005; 39(2): 123–133.
- McNamee KM, Dawood F, Farquharson RG, et al. Thrombophilia and early pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2012; 26(1): 91–102.
- Singer JB. Candidate gene association analysis. Methods Mol Biol. 2009; 573: 223–230.
- Skrzypczak J, Rajewski M, Wirstlein P, et al. [Incidence of hereditary thrombophilia in women with pregnancy loss in multi-center studies in Poland]. Ginekol Pol. 2012; 83(5): 330–336.
- Sergi C, Al Jishi T, Walker M. Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association. Arch Gynecol Obstet. 2015; 291(3): 671–679.
- Baumann K, Beuter-Winkler P, Hackethal A, et al. Maternal factor V Leiden and prothrombin mutations do not seem to contribute to the occurrence of two or more than two consecutive miscarriages in Caucasian patients. Am J Reprod Immunol. 2013; 70(6): 518–521.
- Bałajewicz-Nowak M, Pityński K, Milewicz T. [The 1691 G > A (factor V Leiden) and 1328 T > C V coagulation factor polymorphisms and recurrent miscarriages]. Ginekol Pol. 2015; 86(1): 46–52.
- Barlik M, Seremak-Mrozikiewicz A, Kraśnik W, et al. [The 20210G>A and 19911A>G polymorphisms of prothrombin gene and recurrent miscarriages]. Ginekol Pol. 2013; 84(10): 830–834.
- Gao H, Tao Fb. Prothrombin G20210A mutation is associated with recurrent pregnancy loss: a systematic review and meta-analysis update. Thromb Res. 2015; 135(2): 339–346.
- Mrozikiewicz PM, Cascorbi I, Ziemer S, et al. Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene. J Am Coll Cardiol. 2000; 36(5): 1520–1525.
- Seremak-Mrozikiewicz A, Drews K, Kurzawińska G, et al. Związek polimorfizmu Arg353Gln czynnika VII krzepnięcia z poronieniami nawracającymi. Ginekol Pol. 2009; 80: 8–13.
- Seremak-Mrozikiewicz A, Drews K, Kurzawinska G, et al. The significance of 1793G>A polymorphism in MTHFR gene in women with first trimester recurrent miscarriages. Neuro Endocrinol Lett. 2010; 31(5): 717–723.
- Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systemic review. Br J Haematol. 2006; 132: 171–196.
- Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10(1): 111–113.
- Hanson NQ, Aras O, Yang F, et al. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem. 2001; 47(4): 661–666.
- Rady PL, Szucs S, Grady J, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet. 2002; 107(2): 162–168.
- Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369(6475): 64–67.
- Faisel F, Romppanen EL, Hiltunen M, et al. Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation. Eur J Hum Genet. 2004; 12(3): 187–191.
- Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3-prime-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996; 88: 3698–3703.
- Green F, Kelleher C, Wilkes H, et al. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 1991; 11(3): 540–546.